as 07-11-2025 3:34pm EST
Stocks
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
Founded: | 2019 | Country: | Singapore |
Employees: | N/A | City: | N/A |
Market Cap: | 43.2M | IPO Year: | 2025 |
Target Price: | N/A | AVG Volume (30 days): | 300.3K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.06 | EPS Growth: | N/A |
52 Week Low/High: | $3.51 - $7.46 | Next Earning Date: | 01-01-0001 |
Revenue: | $35,406 | Revenue Growth: | -52.05% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
CUPR Breaking Stock News: Dive into CUPR Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
GlobeNewswire
a month ago
GlobeNewswire
2 months ago
TipRanks
2 months ago
GlobeNewswire
2 months ago
The information presented on this page, "CUPR CUPRINA HOLDINGS (CAYMAN) LIMITED - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.